# Pain management

Rating: Speculative — Little primary evidence yet: mechanism, anecdote or tradition
Type: Guide
Updated: 2026-08-06
Canonical: https://heretic.bio/articles/pain-management.html

> This guide sorts pain by mechanism (nociceptive, neuropathic, nociplastic) and matches tools to each. The best-documented agent here is topical DMSO, a transdermal carrier with anti-inflammatory properties: one controlled trial supports it in complex regional pain syndrome, and it is FDA-approved for interstitial cystitis. Other options range from moderate-evidence topical NSAIDs to preclinical peptides. The framework's claim that root-cause treatment beats symptom suppression is a position, not a tested outcome.

> Integrative pain management in the Heretic framework prioritizes addressing root causes of pain rather than symptom suppression. This file covers DMSO therapy as a transdermal carrier and anti-inflammatory agent, topical analgesic protocols, and the intersection of pain with broader biohacking approaches including peptide therapy, regenerative medicine, and nervous system modulation.

* * *

## Overview

Pain is a bioplastic signal — it reflects the state of the nervous system, inflammatory milieu, and tissue integrity. Effective pain management requires distinguishing between:

Pain Type | Mechanism | Primary Treatment Approach  
---|---|---  
**Nociceptive** | Tissue damage/inflammation | Anti-inflammatory, regenerative  
**Neuropathic** | Nerve damage/dysfunction | Nervous system modulation, peptides  
**Nociplastic** | Sensitized nervous system | DOWNREGULATION, lifestyle, peptides  
**Mixed** | Multiple mechanisms | Multi-modal approach  
  
The conventional approach — NSAIDs, opioids, corticosteroids — primarily suppresses the signal without addressing the cause. The integrative approach asks: _why does this tissue generate pain, and what can we do about the underlying pathophysiology?_

* * *

## DMSO (Dimethyl Sulfoxide)

### What is DMSO?

DMSO is a sulfur-based organic compound (CH₃SOCH₃) that has been used clinically since the 1960s. Its primary clinically useful property is **penetration enhancement** — it rapidly penetrates skin and membranes, carrying other compounds with it. It also has independent anti-inflammatory, analgesic, and antioxidant properties.

### Mechanisms of Action

Mechanism | Evidence | Clinical Relevance  
---|---|---  
**Transdermal carrier** | Well-established | Enables delivery of NSAIDs, herbs, analgesics through skin  
**Membrane fluidity modification** | Basic science | May improve cellular repair signaling  
**Anti-inflammatory** (via NF-κB inhibition) | Moderate | Comparable to some NSAIDs in topical form  
**Antioxidant** (scavenges hydroxyl radicals) | In vitro | May reduce oxidative damage in injured tissues  
**Vasodilation** | Observed clinically | Improves local blood flow  
**Collagen modulation** | Preliminary | May support connective tissue repair  
  
### FDA-Approved and Off-Label Uses

Use | Status | Formulation  
---|---|---  
**Interstitial cystitis** | FDA-approved ( symptomatic relief) | 50% DMSO intravesical instillation  
**Amyloidosis** | FDA-approved (rare) | DMSO IV  
**Topical analgesia** | Off-label | 40-90% topical DMSO  
**Scar tissue / fibrosis** | Off-label | Topical DMSO + compounds  
**CRPS (Complex Regional Pain Syndrome)** | Off-label, evidence-based | Topical DMSO 50%  
**Plantar fasciitis** | Off-label | Topical DMSO + NSAIDs  
  
### Evidence for Specific Applications

#### CRPS (Complex Regional Pain Syndrome)

A controlled trial ( PMID [22266201](https://pubmed.ncbi.nlm.nih.gov/22266201/)) found that **topical DMSO 50%** was effective for CRPS I, with side effects being rare and overall relief significant. CRPS represents one of the strongest evidence-based uses for topical DMSO.

#### As a Penetration Enhancer

DMSO's ability to enhance transdermal drug delivery is well-documented ( PMID [22030943](https://pubmed.ncbi.nlm.nih.gov/22030943/)). It works by: \- Disrupting stratum corneum lipid structure \- Increasing partition coefficient for drugs \- Enabling delivery of both lipophilic and hydrophilic compounds

#### Neuropathic Pain

Early clinical evidence suggests topical DMSO may help with neuropathic pain, though robust RCT data is limited.

### Uses

#### DMSO Compound Combinations

DMSO can carry multiple compounds transdermally. Common combinations:

Combination | Concentration in DMSO Solution | Purpose  
---|---|---  
**DMSO + Ibuprofen** | 10-20% ibuprofen gel dissolved in DMSO | Anti-inflammatory + carrier  
**DMSO + Magnesium** | 10% magnesium chloride hexahydrate | Muscle relaxation, nerve stabilization  
**DMSO + Methylsulfonylmethane (MSM)** | 10% MSM | Sulfur donor, anti-inflammatory  
**DMSO + Lidocaine** | 2-5% lidocaine | Acute pain relief  
**DMSO + Vitamin B12** | Cyanocobalamin solution | Nerve health (theoretical)  
**DMSO + Corticosteroid** | 1% hydrocortisone | Potent anti-inflammatory (short-term use only)  
  
#### DMSO for Systemic Administration (IV/Intraperitoneal)

  * **IV DMSO** is used in some integrative oncology and autoimmune protocols
  * Requires medical supervision; typically 10-50% solution
  * Significant risk if impurities present — pharmaceutical-grade DMSO only
  * Not recommended outside of clinical settings



### DMSO Quality and Handling

Concern | Recommendation  
---|---  
**Purity** | Use only USP/pharmaceutical grade DMSO (99.9%+ purity)  
**Dilution** | Always dilute before topical use — never apply full-strength  
**Solvents** | Use distilled or sterile water for dilution  
**Storage** | Keep sealed, dark, room temperature; DMSO absorbs containers  
**Contamination** | Use glass or HDPE plastic; avoid PVC (leaches plasticizers)  
**Body odor** | DMSO metabolizes to dimethyl sulfide (DMS) — causes garlic-like body odor; harmless  
**Herxheimer reactions** | In some cases, initial worsening of symptoms due to microbial die-off  
  
### Contraindications and Cautions

Contraindication | Reason  
---|---  
**Pregnancy** | Not established as safe  
**Asthma** | Inhaled DMSO vapor may irritate airways  
**Cardiac conduction abnormalities** | IV DMSO may affect cardiac rhythm (theoretical)  
**Liver/kidney dysfunction** | Impaired DMSO metabolism  
**Concurrent grapefruit juice** | Theoretical interaction concerns  
  
### Common Side Effects

Side Effect | Frequency | Management  
---|---|---  
**Garlic-like body odor** | Very common | Manageable; DMS byproduct  
**Skin irritation/rash** | Occasional | Dilute further; reduce frequency  
**GI upset** | Rare (oral/IV) | Not used orally  
**Photosensitivity** | Rare | Avoid sun exposure on treated area  
**Headache** | Rare | Usually resolves with dose reduction  
  
* * *

## Uses

### Conventional Topical NSAIDs

Compound | Formulation | Indication | Evidence  
---|---|---|---  
**Diclofenac gel 1%** | Voltaren Gel | Osteoarthritis, musculoskeletal | RCTs — moderate evidence  
**Ketoprofen gel** | Compounded 10-20% | Tendinopathy, arthritis | Moderate evidence  
**Indomethacin gel** | Various | Inflammation, joint pain | Moderate evidence  
**Capsaicin** | 0.025-0.075% | Neuropathic, arthritic | Good evidence for neuropathic  
**Lidocaine 5%** | Patch or gel | Neuropathic, localized | Good for post-herpetic neuralgia  
  
### Natural Topical Analgesics

Agent | Mechanism | Concentration | Evidence  
---|---|---|---  
**Arnica montana** | Anti-inflammatory (helenalin) | 10-20% gel/cream | Mixed; widely used for trauma  
**Boswellia (Frankincense)** | 5-lipoxygenase inhibition | 5-15% cream | Moderate for osteoarthritis  
**Ginger extract** | Anti-inflammatory, warming | 5-10% | Preliminary  
**Turmeric/Curcumin** | NF-κB inhibition | 3-10% | Preliminary  
**MSM** | Sulfur donor, anti-inflammatory | 10% | Theoretical  
**Menthol** | TRPM8 activation → cooling sensation | 1-5% | Symptomatic relief  
**Camphor** | TRPV3 activation → warming | 1-10% | Symptomatic relief  
  
### Cannabinoid Topicals (Where Legal)

Agent | Mechanism | Application | Evidence  
---|---|---|---  
**CBD (cannabidiol)** | CB2 activation, TRPV1 | 2-10% cream/gel | Growing evidence for chronic pain  
**THC** | CB1/CB2 | 1-5% (not psychoactive transdermally) | Preliminary  
**Full-spectrum** | Entourage effect | 5-10% | Anecdotal > evidence  
  
* * *

## Peptide-Based Pain Management

Several peptides have demonstrated analgesic or healing-promoting properties relevant to pain management:

### BPC-157 (Body Protection Compound)

**Primary relevance** : Healing of GI tract, tendons, ligaments, and nerves — addressing root causes of pain rather than symptom suppression.

Property | Detail  
---|---  
**Mechanism** | Upregulates growth hormone receptors, promotes angiogenesis, stabilizes cell membranes  
**Pain application** | Tendinopathy, joint pain, nerve injury, post-surgical  
**Dosing** | —  
**Evidence** | Strong preclinical; limited human RCTs  
**PMID** | See [BPC-157 (Body Protection Compound)](bpc-157-body-protection-compound.html)  
  
### TB-500 (Thymosin Beta-4)

Property | Detail  
---|---  
**Mechanism** | Promotes cell migration, reduces inflammation, supports tissue repair  
**Pain application** | Muscle injuries, wound healing, anti-inflammatory  
**Dosing** | —  
**Evidence** | Preclinical strong; human data limited  
**PMID** | See [TB-500 (Thymosin Beta-4)](tb-500-thymosin-beta-4.html)  
  
### Khavinson Peptides (Russian Bioregulators)

Property | Detail  
---|---  
**Relevance** | May support tissue regeneration and nervous system function  
**Notable** | Cortexin (brain/pain), retinalamins (eye), thymulin (immune)  
**Evidence** | Soviet clinical tradition; limited Western RCTs  
**PMID** | See [Khavinson Peptides (Russian Bioregulators)](peptide-bioregulation-khavinson.html)  
  
* * *

## Uses

### Uses

Phase | Intervention  
---|---  
**0-20 min** | Rest, protect, control swelling  
**20 min-72 hrs** | —  
**Anti-inflammatory** | —  
**Peptide support** | —  
**After acute** | Begin gentle loading and physical therapy  
**For pain** | Topical DMSO + ibuprofen as needed  
  
### Uses

Agent | Mechanism  
---|---  
**Alpha-lipoic acid** | Oxidative stress reduction, nerve conduction  
**Acetyl-L-carnitine** | Nerve mitochondrial function  
**Benfotiamine** | Thiamine pyrophosphate; nerve energy  
**Magnesium** | NMDA modulation  
**Topical DMSO + lidocaine** | Local nerve stabilization  
**BPC-157** | Nerve healing (theoretical)  
  
* * *

## Pain and the Nervous System

### Central Sensitization

Chronic pain often involves **wind-up** and **central sensitization** — the CNS amplifies pain signals beyond the peripheral input. Addressing this requires:

Approach | Mechanism  
---|---  
**Vagus nerve stimulation** | Activates descending inhibitory pathways  
**Breathwork / coherent breathing** | Reduces sympathetic tone  
**Cold exposure** | Norepinephrine release → pain inhibition  
**Sleep restoration** | CNS glymphatic clearance  
**Ketamine (low-dose)** | NMDA antagonism  
**Psilocybin (clinical trials)** | Neuroplasticity, default mode network reset  
  
### Pain and the Polyvagal Connection

Stephen Porges' Polyvagal Theory suggests that the ventral vagal state is incompatible with chronic pain states — engaging social engagement and safety physiology may directly reduce pain sensitivity. See [Polyvagal Theory](polyvagal-theory.html).

* * *

## Notes

  * **NSAIDs** : Useful short-term for acute inflammation but carry GI, cardiovascular, and renal risks with chronic use; topical forms reduce systemic exposure
  * **Opioids** : Outside appropriate acute/post-surgical contexts, chronic opioid therapy for non-cancer pain is generally counterproductive and harmful
  * **Steroid injections** : Provide temporary relief but may impair tendon/ligament integrity with repeated use
  * **DMSO quality is critical** : Industrial DMSO contains impurities that can be carried transdermally — use only pharmaceutical-grade
  * **The pain-immune connection** : Chronic pain and immune activation are intertwined; addressing systemic inflammation often reduces pain



* * *

## Practical Context

### When to Use DMSO

Situation | DMSO Useful?  
---|---  
**Acute musculoskeletal injury** | Yes — early anti-inflammatory effect  
**Chronic joint pain (osteoarthritis)** | Yes — disease modification potential  
**Neuropathic pain** | Moderate — as adjunct  
**CRPS** | Yes — relatively strong evidence  
**Tendinopathy** | Yes — penetrates deep tissue  
**Post-herpetic neuralgia** | Moderate — as adjunct  
**Headache (tension-type)** | Possibly — topical to neck/temples  
**Acute migraine** | Not recommended  
  
### Storage and Handling

  * DMSO crystallizes at low temperatures (18°C/65°F) — warm to dissolve before use
  * Use glass droppers or HDPE plastic — never PVC
  * DMSO will dissolve plastic and leach chemicals from unsuitable containers
  * Apply to clean skin only — carries anything on the skin surface into the body



* * *

## Sources

1. PubMed 22266201 (PubMed 22266201)
2. PubMed 22030943 (PubMed 22030943)